Andrew Jea to Risk Assessment
This is a "connection" page, showing publications Andrew Jea has written about Risk Assessment.
Connection Strength
0.231
-
Survey of the Effectiveness of Internet Information on Patient Education for Bone Morphogenetic Protein. World Neurosurg. 2016 Mar; 87:613-8.
Score: 0.108
-
Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. J Neurosurg Pediatr. 2015 Jul; 16(1):4-13.
Score: 0.104
-
Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr. 2011 Feb; 7(2):147-51.
Score: 0.019